Yanbin WANG

Person

Nanjing, Jiangsu, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Engineered immune cell and use thereof
- Patent number 11,896,620
- Issue date Feb 13, 2024
- BIOHENG THERAPEUTICS LIMITED
- Yun Xing
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
NOVEL CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
- Publication number 20240082306
- Publication date Mar 14, 2024
- BIOHENG THERAPEUTICS LIMITED
- Yali ZHOU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ROR1-TARGETING ANTIBODY AND USE THEREOF
- Publication number 20240052029
- Publication date Feb 15, 2024
- BIOHENG THERAPEUTICS LIMITED
- Yali ZHOU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NKG2A-TARGETING ANTIBODY AND USE THEREOF
- Publication number 20240043532
- Publication date Feb 8, 2024
- BIOHENG THERAPEUTICS LIMITED
- Yali ZHOU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD19-TARGETING HUMANIZED ANTIBODY AND USE THEREOF
- Publication number 20240018236
- Publication date Jan 18, 2024
- BIOHENG THERAPEUTICS LIMITED
- Yali ZHOU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BCMA-TARGETING SINGLE-DOMAIN ANTIBODY AND USE THEREOF
- Publication number 20240018251
- Publication date Jan 18, 2024
- BIOHENG THERAPEUTICS LIMITED
- Guokun LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR COMPRISING NOVEL CO-STIMULATORY DOMAIN AN...
- Publication number 20240009308
- Publication date Jan 11, 2024
- Yali ZHOU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED IMMUNE CELL AND USE THEREOF
- Publication number 20240009311
- Publication date Jan 11, 2024
- NANJING BIOHENG BIOTECH CO., LTD
- Yun XING
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD7-TARGETING HUMANIZED ANTIBODY AND USE THEREOF
- Publication number 20230399398
- Publication date Dec 14, 2023
- BIOHENG THERAPEUTICS LIMITED
- Yali ZHOU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR TARGETING CD7 AND USE THEREOF
- Publication number 20230390336
- Publication date Dec 7, 2023
- BIOHENG THERAPEUTICS LIMITED
- Yali ZHOU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL CO-STIMULATORY DOMAIN AND USE THEREOF
- Publication number 20230270858
- Publication date Aug 31, 2023
- NANJING BIOHENG BIOTECH CO., LTD
- Yali ZHOU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED IMMUNE CELL FOR ALLOTRANSPLANTATION
- Publication number 20230248768
- Publication date Aug 10, 2023
- NANJING BIOHENG BIOTECH CO., LTD
- Yali ZHOU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED IMMUNE CELL EXPRESSING NK INHIBITORY MOLECULE AND USE TH...
- Publication number 20230242661
- Publication date Aug 3, 2023
- NANJING BIOHENG BIOTECH CO., LTD
- Yali ZHOU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNE CELL COMPRISING CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
- Publication number 20230242877
- Publication date Aug 3, 2023
- NANJING BIOHENG BIOTECH CO., LTD
- Qiping SHI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED IMMUNE CELL AND USE THEREOF
- Publication number 20230138756
- Publication date May 4, 2023
- NANJING BIOHENG BIOTECH CO., LTD
- Yun XING
- C07 - ORGANIC CHEMISTRY

Yanbin WANG

Person

Patents Grantslast 30 patents

Engineered immune cell and use thereof

Patents Applicationslast 30 patents

NOVEL CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

ROR1-TARGETING ANTIBODY AND USE THEREOF

NKG2A-TARGETING ANTIBODY AND USE THEREOF

CD19-TARGETING HUMANIZED ANTIBODY AND USE THEREOF

BCMA-TARGETING SINGLE-DOMAIN ANTIBODY AND USE THEREOF

CHIMERIC ANTIGEN RECEPTOR COMPRISING NOVEL CO-STIMULATORY DOMAIN AN...

ENGINEERED IMMUNE CELL AND USE THEREOF

CD7-TARGETING HUMANIZED ANTIBODY AND USE THEREOF

CHIMERIC ANTIGEN RECEPTOR TARGETING CD7 AND USE THEREOF

NOVEL CO-STIMULATORY DOMAIN AND USE THEREOF

ENGINEERED IMMUNE CELL FOR ALLOTRANSPLANTATION

ENGINEERED IMMUNE CELL EXPRESSING NK INHIBITORY MOLECULE AND USE TH...

IMMUNE CELL COMPRISING CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

ENGINEERED IMMUNE CELL AND USE THEREOF